Drug intelligence / Profile preview

neomycin sulfate + polymyxin b sulfate

Development stage
Approved
Lead developer
Amring Pharmaceuticals
Modality
Small Molecules
Administration
Topical, Ophthalmic, Otic
01

Overview

Neomycin sulfate + polymyxin b sulfate is a **combination of two antibiotics**—neomycin sulfate (an aminoglycoside) and polymyxin B sulfate (a polypeptide). This combination is included in various formulations, most commonly as ophthalmic or otic solutions, ointments, and suspensions, for the treatment and prevention of superficial infections caused by susceptible bacteria. - **Neomycin sulfate** acts by binding to bacterial ribosomal RNA, causing misreading of mRNA and inhibiting protein synthesis, ultimately leading to bacterial cell death. - **Polymyxin B sulfate** interacts with the phospholipids of the bacterial cell membrane of Gram-negative bacteria, increasing membrane permeability and causing cell lysis. The combination is active against a range of bacteria, including *Staphylococcus aureus*, *Escherichia coli*, *Haemophilus influenzae*, *Klebsiella/Enterobacter* species, *Neisseria* species, and *Pseudomonas aeruginosa*, but lacks adequate coverage for *Serratia marcescens* and many streptococci[1][2]. Indications include superficial bacterial infections (skin, eye, and ear) and prevention of infection in minor skin injuries.

Brand names
Neosporin G.U. Irrigant
Other names
neomycin and polymyxin bpolymyxin b and neomycin
02

Targets

Bacterial RibosomeLPS (Lipopolysaccharide)

Beyond the preview

Go deeper on neomycin sulfate + polymyxin b sulfate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on neomycin sulfate + polymyxin b sulfate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call